Morning Briefing
Summaries of health policy coverage from major news organizations
Medicare Moves To Pay For Provenge
On Wednesday, Medicare officials signaled the federal insurance program will pay for this costly prostate cancer drug, a move that National Journal described as heading off "accusations that the [government] would be 'rationing' care."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
